Healthcare industry

Article - 18-Aug-2014

Biometry: Peter Martus works at the interface of mathematics and medicine

It’s not computer science, but it’s close to data: Prof. Dr. Peter Martus has an in-depth knowledge of how professional biotechnology and medical statistics are generated. Prof. Martus works at the University of Tübingen where he brings his know-how to clinical trials as well as working on life sciences projects where statistical issues need to be resolved.

Article - 30-Apr-2011

The DKFZ-ZMBH Alliance

The strategic alliance between the cell and tumour biology research priority at the German Cancer Research Center and the Center for Molecular Biology at Universität Heidelberg has led to the development of one of the largest centres of basic biomedical research in Germany. The top international profile of this interdisciplinary institution located at the interface between molecular and cellular biology tumour biology and biomedicine is reflected in the high-calibre speakers who will give presentations at the DKFZ-ZMBH Alliance Forum on Aging Cancer to be held in Heidelberg between 19th and 21st May 2011.

Article - 22-Mar-2010

IBR Inc.: Dual strategy for safe and effective drugs

IBR Inc. a science-based provider of preclinical and clinical services specialises in inflammatory diseases. The analyses it carries out for the pharmaceutical and biotech sector help exclude potential side effects of specific drug candidates early in the development process.

Article - 08-Dec-2009

Karl Stock helps turn ideas into products

Karl Stock takes abstract ideas and turns them into useable technological possibilities. The 44-year-old works in what could best be described as the one-man engineering office at the Ulm-based Institute of Laser Technologies in Medicine and Metrology (ILM). In contrast to university institutes, Stock’s work does not simply finish with a “paper” published in a journal. Stock strives to go further and his real work starts where others often stop, and this extra work may well lead to a functional model or prototype.

Article - 22-Oct-2010

Christian Bonten focuses mainly on bioplastics

Prof. Dr. Christian Bonten has been head of the Institute for Polymer Technology IKT at the University of Stuttgart since 1st September 2010. The former Institute for Plastics Testing and Science has recently become part of the IKT and has therefore come under Bontens area of responsibility. Bonton believes that bioplastics have great future potential and he plans to set milestones to drive bioplastics development forward.

Article - 17-May-2010

Dietmar Hopp: Awarded Great Cross of Merit on his 70th birthday

Dietmar Hopp entrepreneur and co-founder of SAP sports patron biotech investor provider of funds and great promoter of his native region has turned 70. To celebrate the occasion the German Federal President has awarded Hopp the Great Cross of Merit of the Federal Republic of Germany Bundesverdienstkreuz which was presented to him by the Baden-Württemberg Minister President Stefan Mappus.

Article - 08-Sep-2014

Molecular effects of traumatic stress

After a traumatic experience, people often suffer not only mental, but also physical effects. Dr. María Moreno-Villanueva from the University of Konstanz has investigated the molecular effects of traumatic stress in people and has found a higher than normal number of DNA strand breaks. In the worst cases this can lead to diseases such as cancer. However, her study also shows that successful psychotherapy can reverse DNA damage. Her findings will contribute to the development of new methods for the diagnosis and therapy of traumatic stress disorders.

Press release - 21-May-2010

The fingerprints of molecules

Prof. Heiko Möller is head of the NMR Core Facility a centre at the University of Constance that focuses on magnetic resonance spectroscopy where fingerprints of molecules are taken. The highly sensitive analysis instruments are used by his group of researchers for research projects on subjects ranging from severed visual nerves cancer protection and the rapid identification of anthrax bacteria.